PATENT CLAIM ANALYSIS

Application Number: 15743327
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "167000"]

Abstract:
Pharmaceutically acceptable cholecalciferol sulfate salts are used for combating vitamin D 3  deficiency. New cholecalciferol sulfate salts as well as pharmaceutical compositions of the pharmaceutically acceptable cholecalciferol sulfate salts are described as well.

Claim (Index 15):
The method of  claim 13 , wherein the administration method is selected from transdermal, transmucosal, intradermal, subcutaneous, intramuscular injection, including sustained-drug-release depot injection.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.52174
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14399195', '14938197', '10903211', '14337028', '14329821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609636212547368
- 35 USC 102 Novelty (BERT): 0.4697141456737642
- Combined Prediction Score: 0.7318386736966396
- Mean Citation Score: 151.19728400000002
- Max Citation Score: 155.36197
- Similarity Product: 117.60819164276602

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test